Article ; Online: Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice.
2023 Volume 20, Issue 11, Page(s) 5901–5909
Abstract: Mucopolysaccharidoses (MPSs) make up a group of lysosomal storage diseases characterized by the aberrant accumulation of glycosaminoglycans throughout the body. Patients with MPSs display various signs and symptoms, such as retinopathy, which is also ... ...
| Abstract | Mucopolysaccharidoses (MPSs) make up a group of lysosomal storage diseases characterized by the aberrant accumulation of glycosaminoglycans throughout the body. Patients with MPSs display various signs and symptoms, such as retinopathy, which is also observed in patients with MPS II. Unfortunately, retinal disorders in MPS II are resistant to conventional intravenous enzyme-replacement therapy because the blood-retinal barrier (BRB) impedes drug penetration. In this study, we show that a fusion protein, designated pabinafusp alfa, consisting of an antihuman transferrin receptor antibody and iduronate-2-sulfatase (IDS), crosses the BRB and reaches the retina in a murine model of MPS II. We found that retinal function, as assessed by electroretinography (ERG) in MPS II mice, deteriorated with age. Early intervention with repeated intravenous treatment of pabinafusp alfa decreased heparan sulfate deposition in the retina, optic nerve, and visual cortex, thus preserving or even improving the ERG response in MPS II mice. Histological analysis further revealed that pabinafusp alfa mitigated the loss of the photoreceptor layer observed in diseased mice. In contrast, recombinant nonfused IDS failed to reach the retina and hardly affected the retinal disease. These results support the hypothesis that transferrin receptor-targeted IDS can penetrate the BRB, thereby ameliorating retinal dysfunction in MPS II. |
|---|---|
| MeSH term(s) | Animals ; Mice ; Blood-Retinal Barrier/metabolism ; Glycosaminoglycans ; Iduronate Sulfatase/metabolism ; Iduronate Sulfatase/therapeutic use ; Iduronic Acid ; Mucopolysaccharidosis II/drug therapy ; Mucopolysaccharidosis II/diagnosis ; Receptors, Transferrin ; Retinal Diseases/drug therapy |
| Chemical Substances | Glycosaminoglycans ; Iduronate Sulfatase (EC 3.1.6.13) ; Iduronic Acid (3402-98-0) ; Receptors, Transferrin ; Ids protein, mouse (EC 3.1.6.13) ; Tfrc protein, mouse |
| Language | English |
| Publishing date | 2023-10-20 |
| Publishing country | United States |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 2138405-8 |
| ISSN | 1543-8392 ; 1543-8384 |
| ISSN (online) | 1543-8392 |
| ISSN | 1543-8384 |
| DOI | 10.1021/acs.molpharmaceut.3c00736 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6250: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.